Meenakshi Balganesh

Title: Meenakshi Balganesh: Innovator in Molecular Biology

Introduction

Meenakshi Balganesh is a notable inventor based in Bengaluru, India. She has made significant contributions to the field of molecular biology, particularly in the development of novel nucleic acid molecules and mycobacterial inhibitors. With a total of 2 patents, her work has the potential to impact various medical applications.

Latest Patents

One of her latest patents focuses on DNA molecules. This invention provides novel nucleic acid molecules coding for sigma subunits of RNA polymerase. It also relates to polypeptides, referred to as SigA and SigB, encoded by such nucleic acid molecules. Additionally, the invention includes vectors and host cells transformed with the said nucleic acid molecules. Furthermore, it provides screening assays for compounds that inhibit the interaction between a sigma subunit and a core RNA polymerase. Another significant patent involves mycobacterial inhibitors, which details the use of certain succinimide compounds in the treatment of mycobacterial diseases.

Career Highlights

Throughout her career, Meenakshi has worked with prominent companies such as AstraZeneca AB and Astra Aktiebolag. Her experience in these organizations has contributed to her expertise in the field of molecular biology and innovation.

Collaborations

Meenakshi has collaborated with several professionals in her field, including Kantharaj Ethirajulu and Babita Singh Ganguly. These collaborations have likely enriched her research and development efforts.

Conclusion

Meenakshi Balganesh is a distinguished inventor whose work in molecular biology has led to valuable patents that may advance medical treatments. Her contributions reflect her dedication to innovation and research in the scientific community.